Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 68788-7524 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a label for Pregabalin Capsules 150mg manufactured by ScieGen Pharmaceuticals, Inc. The caution mentions that federal law prohibits the transfer of the medication to a non-patient. The text also includes information on the drug's dosage, ingredients, lot number, expiration date, and generic name, Lyrica.*
The text shows a chart displaying percent of patients improved with the use of Pregabalin at 300mg and 450mg daily doses compared to placebo. The chart also indicates the percent improvement in pain from baseline.*
The text appears to be a chart or graph showing the estimated percentage of subjects without "LTR" for two treatments, Progabain and Placebo, over a period of 120 days. The percentages range from 0% to 100%. There are no further details available.*
This text appears to be a formula for calculating CLCT (Creatinine Clearance). It involves multiplying a value obtained by taking 140 minus the patient's age in years by their weight in kilograms. The resulting value is then adjusted by multiplying it by 0.85 for female patients. The second part of the formula involves multiplying 72 by the level of serum creatinine in mg/dL. It is unclear what the purpose of CLCT is or how this formula is used without additional context.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.